Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines
Gilead Sciences, Inc. (Nasdaq: GILD) today celebrated the opening of its 182,000-square-foot Research Center at its Foster City headquarters, expanding capabilities in oncology, inflammation and research data science to advance medicines for some of the worlds most challenging diseases. The new...